|
OTUD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.206200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.466000E-02 |
| Normal-vs-Stage2 |
4.066400E-01 |
| Normal-vs-Stage3 |
6.910000E-02 |
| Normal-vs-Stage4 |
4.479000E-01 |
| Stage1-vs-Stage2 |
5.614000E-01 |
| Stage1-vs-Stage3 |
7.879800E-01 |
| Stage1-vs-Stage4 |
4.759200E-01 |
| Stage2-vs-Stage3 |
5.010400E-01 |
| Stage2-vs-Stage4 |
9.316200E-01 |
| Stage3-vs-Stage4 |
4.279600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.678500E-02 |
| Normal-vs-AfricanAmerican |
7.321200E-01 |
| Normal-vs-Asian |
9.368400E-01 |
| Caucasian-vs-AfricanAmerican |
5.612800E-01 |
| Caucasian-vs-Asian |
1.567550E-01 |
| AfricanAmerican-vs-Asian |
6.925400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.699800E-02 |
| Normal-vs-Female |
9.668300E-02 |
| Male-vs-Female |
5.080400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.253610E-01 |
| Normal-vs-Age(61-80Yrs) |
1.008800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.168600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.745200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.124200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.226200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.104000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.360600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.371400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.257970E-02 |
| Classical-VS-Follicular |
2.770300E-04 |
| Classical-VS-Other |
1.166000E-01 |
| Classical-VS-Normal |
6.784600E-01 |
| Tall-VS-Follicular |
7.225800E-01 |
| Tall-VS-Other |
4.975000E-01 |
| Tall-VS-Normal |
1.751800E-02 |
| Follicular-VS-Other |
7.218600E-01 |
| Follicular-VS-Normal |
2.283500E-03 |
| Other-VS-Normal |
4.352400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.191800E-02 |
| Normal-vs-N1 |
2.308600E-01 |
| N0-vs-N1 |
4.145400E-01 |
|
|
